Holding(s) in Co.-Replacement
23 1월 2004 - 9:29PM
UK Regulatory
RNS Number:5753U
Volex Group PLC
23 January 2004
Replacement Anouncement for Volex Group p.l.c.
The following replaces the Notification of Major Share Interest announcement
released today at 11.28am under RNS number 5703U.
Section 13, "Total percentage holding of issued class following this
notification", is 3.67% and not 3.76% as previously stated.
All other details remain unchanged, and the full amended text appears below.
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
VOLEX GROUP PLC
2. Name of shareholder having a major interest
UBS Global Asset Management Life Ltd.
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18
Holding of shareholder named in 2 above.
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
Phildrew Nominees Limited a/c LF20
5. Number of shares / amount of stock acquired
-
6. Percentage of issued class
-
7. Number of shares / amount of stock disposed
Not Disclosed
8. Percentage of issued class
Not Disclosed
9. Class of security
Ordinary 25p
10. Date of transaction
Not Disclosed
11. Date company informed
23rd January 2004
12. Total holding following this notification
1,050,971
13. Total percentage holding of issued class following this notification
3.67%
14. Any additional information
UBS Global Asset Management Life Ltd is a subsidiary of UBS Global Asset
Management Holding (No.2) Ltd which is also treated as having an interest in
the shareholding disclosed above.
15. Name of contact and telephone number for queries
Mark Ashcroft - 01925 830101
16. Name and signature of authorised company official responsible for making
this notification
Mark Ashcroft, Director and Company Secretary
Date of notification
23rd January 2004
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLILFFFLLIVFIS